Useful Info: Coronavirus Update 21st March 2020

Please see link to Rapid guidelines systemic anticancer treatments.

here: https://www.nice.org.uk/covid-19

 

and

 

Message from our Independent Sector Rep on the BOPA commitee, Netty Cracknell:

I have been informed of the following: In response to the national health emergency in the UK posed by the spread of Covid – 19, all parts of the UK health system have come together in order to provide a joined up, consistent service to the general public.
The whole of the UK health service including all Independent Providers will be working as one system, in order to ensure capacity and resource to its fullest potential to deal with the national Covid-19 crisis.

I believe this is being done at cost, meaning no profit will be made for doing so.

I am assuming more information will follow but urge all NHS and IS pharmacists who are geographically close to contact each other now. Please use the BOPA forum to find people if needed.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article